[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Pages 65592-65593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23641]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis (ACET). This meeting is open to the public 
and limited to 1,000 audio and web conference lines. Members of the 
public are welcome to listen to the meeting by accessing the telephone 
number and web access provided in the addresses section below. Time 
will be available for public comment (registration required to provide 
oral comment).

DATES: The meeting will be held on December 13, 2022, from 10:00 a.m. 
to 5:00 p.m., EST, and December 14, 2022, from 10:00 a.m. to 12:00 
p.m., EST. Written comments must be submitted by November 29, 2022. 
Registration to make oral comments must also be submitted by November 
29, 2022.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
161 095 9944, and the Passcode is 42236876. The web conference access 
is https://cdc.zoomgov.com/j/1610959944?pwd=eGhxZFNaeFJscGo2eTVwZ0ZOZ3d4QT09, and the Passcode

[[Page 65593]]

is E=7@trcA. The number of available audio and web conference lines is 
1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, 
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 30329-4027; 
Telephone: (404) 639-3423; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis (TB). Specifically, the Council makes recommendations 
regarding policies, strategies, objectives, and priorities; addresses 
the development and application of new technologies; and reviews the 
extent to which progress has been made toward eliminating tuberculosis.
    Matters To Be Considered: The agenda will include discussions on 
(1) electronic data systems for overseas medical evaluations; (2) TB 
commercial diagnostics; (3) TB screening in the Uniting for Ukraine 
response; (4) CDC electronic directly observed therapy recommendations; 
and (5) the TB Elimination Alliance. Agenda items are subject to change 
as priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with subject line 
``December 2022 ACET Public Comment Registration'' by November 29, 
2022.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``December 2022 ACET Public 
Comment Registration'' by November 29, 2022. The public comment period 
is on December 13, 2022, at 4:45 p.m., EST.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-23641 Filed 10-28-22; 8:45 am]
BILLING CODE 4163-18-P